PLIAGLIS

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

64 API Suppliers, 19 USDMF, 6 CEP/COS, 5 JDMF, 7 EU WC, 9 KDMF, 21 NDC API, 30 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

164 Drugs in Development

164 Drugs in Development

INTERMEDIATES

3 Intermediate Suppliers

3 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

274 FDF Dossiers, 53 FDA Orange Book, 121 Europe, 19 Canada, 3 Australia, 14 South Africa, 64 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

CREAM;TOPICAL - 2.5%;2.5% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, PATCH;TOPICAL - 5%, PATCH;TOPICAL - 70MG;70MG, CREAM;TOPICAL - 7%;7%

RELATED EXCIPIENT COMPANIES

2 EUROAPI, 1 Minakem, 3 Evonik, 3 Rochem International Inc, 12 SPI Pharma, 20 DKSH, 1 PMC Isochem, 1 Pharm-RX Chemical, 9 Boai NKY Pharmaceuticals Ltd, 3 Gangwal Healthcare, 2 Kewpie Corporation, 23 Nanjing Well Pharmaceutical, 1 Shanghai Minbiotech, 2 Pfanstiehl, 1 Capital Farma, 17 Kirsch Pharma, 4 ACG Worldwide, 17 Actylis, 3 Aeon Procare, 2 Alcedo Pharmachem, 6 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 3 Ashland, 52 BASF, 1 Bioplus Life Sciences, 1 BioSpectra, 5 CD Formulation, 3 Clariant, 13 Corel Pharma Chem, 1 DFE Pharma, 3 Doshion Polyscience, 3 Esteem Industries, 5 Finar, 18 Gangwal Chemicals, 1 Huzhou Sunflower Pharmaceutical, 1 Ideal Cures, 3 Ingredion Pharma Solutions, 5 Kerry, 3 Keval Exports, 1 Kima Chemical, 3 Lonza Capsugel, 8 Lubrizol Life Science Health, 17 Microlex e.U, 4 Nanjing Bold Chemical, 3 Nippon Fine Chemical, 1 Nitika Pharmaceutical Specialities, 2 Nomisma Healthcare, 4 Novo Excipients, 2 Pharmatrans-Sanaq, 7 Pluviaendo, 3 Prachin Chemical, 1 Qualicaps, 19 Roquette, 16 Seppic, 2 Shandong Focus Biotechnology Co., Ltd, 4 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 4 Sigachi Industries, 2 Silverline Chemicals, 2 Symrise, 1 The Dow Chemical Company, 2 Ulanqab Kema New Material, 2 Valens Pharmachem, 2 Vasa Pharmachem, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

89 Topical, 76 Solubilizers, 61 Thickeners and Stabilizers, 57 Fillers, Diluents & Binders, 53 Parenteral, 39 Emulsifying Agents, 31 Coating Systems & Additives, 31 Disintegrants & Superdisintegrants, 29 Direct Compression, 28 Film Formers & Plasticizers, 26 Lubricants & Glidants, 25 Granulation, 24 Surfactant & Foaming Agents, 20 Controlled & Modified Release, 19 Taste Masking, 15 Rheology Modifiers, 12 Chewable & Orodispersible Aids, 12 Co-Processed Excipients, 8 Empty Capsules, 7 API Stability Enhancers, 2 Coloring Agents, 1 Dry Powder Inhalation, 1 Soft Gelatin

DIGITAL CONTENT

113 News #PharmaBuzz

113 News #PharmaBuzz

GLOBAL SALES INFORMATION

34 US Medicaid Prescriptions, 78 Regulatory FDF Prices, 4 Annual Reports

MARKET PLACE

31 APIs, 23 FDF Dossiers

PATENTS & EXCLUSIVITIES

11 US Patents, 3 Health Canada Patents

REF. STANDARDS & IMPURITIES

1 EDQM, 13 Others

$ Xls

Filters

Digital Content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

Enforcement Report - Week of July 30, 2025

30 Jul 2025

// FDA

Enforcement Report - Week of July 9, 2025

09 Jul 2025

// FDA

Enforcement Report - Week of July 2, 2025

02 Jul 2025

// FDA

Crescita Therapeutics Terminate Licensing Agreement for Pliaglis

23 May 2025

// BUSINESSWIRE

Dr. Stephen Innovates Safer Facial Surgery With In-Office Sedation

18 Apr 2025

// ACCESSWIRE

Armas Pharmaceuticals Reintroduces Lidocaine Jelly 2% 30mL in U.S

27 Mar 2025

// PR NEWSWIRE

PLIAGLIS

PLIAGLIS

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

64 API Suppliers

19 USDMF

6 CEP/COS

5 JDMF

7 EU WC

9 KDMF

21 NDC API

30 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

164 Drugs in Development

INTERMEDIATES

3 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

274 FDF Dossiers

53 FDA Orange Book

121 Europe

19 Canada

3 Australia

14 South Africa

64 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

CREAM;TOPICAL - 2.5%;2.5% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

PATCH;TOPICAL - 5%

PATCH;TOPICAL - 70MG;70MG

CREAM;TOPICAL - 7%;7%

RELATED EXCIPIENT COMPANIES

2 EUROAPI

1 Minakem

3 Evonik

3 Rochem International Inc

12 SPI Pharma

20 DKSH

1 PMC Isochem

1 Pharm-RX Chemical

9 Boai NKY Pharmaceuticals Ltd

3 Gangwal Healthcare

2 Kewpie Corporation

23 Nanjing Well Pharmaceutical

1 Shanghai Minbiotech

2 Pfanstiehl

1 Capital Farma

17 Kirsch Pharma

4 ACG Worldwide

17 Actylis

3 Aeon Procare

2 Alcedo Pharmachem

6 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

3 Ashland

52 BASF

1 Bioplus Life Sciences

1 BioSpectra

5 CD Formulation

3 Clariant

13 Corel Pharma Chem

1 DFE Pharma

3 Doshion Polyscience

3 Esteem Industries

5 Finar

18 Gangwal Chemicals

1 Huzhou Sunflower Pharmaceutical

1 Ideal Cures

3 Ingredion Pharma Solutions

5 Kerry

3 Keval Exports

1 Kima Chemical

3 Lonza Capsugel

8 Lubrizol Life Science Health

17 Microlex e.U

4 Nanjing Bold Chemical

3 Nippon Fine Chemical

1 Nitika Pharmaceutical Specialities

2 Nomisma Healthcare

CREAM;TOPICAL - 2.5%;2.5% Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons